Literature DB >> 33402308

Probable parenteral and oral contrast-induced Steven Johnson syndrome/toxic epidermal necrolysis.

Marianne Pop1, Alice Hemenway2, Faizan Shakeel3.   

Abstract

We report a case of contrast-inducted Steven Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN). The patient had received parenteral iopamidol and oral iohexol five days prior. The patient's chief complaint at the Emergency Department (ED) presentation was shortness of breath and blisters throughout body. Upon arrival, the patient was awake, alert, and oriented with a blood pressure (BP) of 166/68, heart rate (HR) of 117 beats per minute, respiratory rate (RR) of 22 breaths per minute and oxygen saturation of 94% on room air. A review of systems was unremarkable with the exception of chills, fatigue and rash. Physical exam was significant for right eye edema/crusting, hemorrhagic bullae, and maculopapular rash. The patient's initial laboratory results were significant for platelets (PLT) of 549 and absolute neutrophil count (ANC) 8.48 × 10(3)/mcL, neutrophils 84.2%, and lymphocytes 10%. Complete metabolic panel was normal with serum creatinine 0.77 mg/dL. The patient was initially treated with diphenhydramine, methylprednisolone, ondansetron, sodium chloride, lorazepam and oxycodone-acetaminophen. Hemotology/Oncology and Trauma/Burn consult identified possible SJS/TEN and the patient was transferred to another facility for dermatologic/burn follow up.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contrast agent; SJS; TENS

Year:  2020        PMID: 33402308     DOI: 10.1016/j.ajem.2020.12.044

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  1 in total

1.  Iodinated contrast-induced Stevens-Johnson syndrome: A report of a rare complication for a common imaging agent.

Authors:  Daniel Carrera; Jesus G Ulloa
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-07-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.